Sanchez, Fevelyn .

HRN: 23-87-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
AMPICILLIN 1GM (VIAL)
11/23/2023
11/30/2023
IV
2gm
Q6
PROM X 3hours
Waiting Final Action 
11/23/2023
CEFUROXIME 500MG (TAB)
11/23/2023
11/30/2023
PO
500mg
BID X 7 Days
S/P NSVD With 2nd Degree Laceration And Repair; PROM X 16 Hours
Waiting Final Action 
11/24/2023
CEFUROXIME 1.5GM (VIAL)
11/24/2023
11/25/2023
IV
1.5gm
Q8
Leukocytosis (25.7)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: